Kaur N - Search Results

1

Levothyroxine Sodium Pentahydrate Tablets - Formulation Considerations.

Kaur N, Suryanarayanan R. Kaur N, et al. J Pharm Sci. 2021 Dec;110(12):3743-3756. doi: 10.1016/j.xphs.2021.08.006. Epub 2021 Aug 10. J Pharm Sci. 2021. PMID: 34384799 Review.

2

Partial Dehydration of Levothyroxine Sodium Pentahydrate in a Drug Product Environment: Structural Insights into Stability.

Kaur N, Young VG Jr, Su Y, Suryanarayanan R. Kaur N, et al. Mol Pharm. 2020 Oct 5;17(10):3915-3929. doi: 10.1021/acs.molpharmaceut.0c00661. Epub 2020 Sep 22. Mol Pharm. 2020. PMID: 32960611

3

Investigating the Influence of Excipients on the Stability of Levothyroxine Sodium Pentahydrate.

Kaur N, Suryanarayanan R. Kaur N, et al. Mol Pharm. 2021 Jul 5;18(7):2683-2693. doi: 10.1021/acs.molpharmaceut.1c00217. Epub 2021 Jun 1. Mol Pharm. 2021. PMID: 34061524

4

Dual Functionality of Bile Acid: Physical Stabilization of Drugs in the Amorphous Form and Solubility Enhancement in Solution.

Lalge R, Kaur N, Duggirala NK, Suryanarayanan R. Lalge R, et al. Among authors: kaur n. Mol Pharm. 2022 Jul 4;19(7):2595-2606. doi: 10.1021/acs.molpharmaceut.2c00294. Epub 2022 Jun 10. Mol Pharm. 2022. PMID: 35687125

5

Role of Lattice Disorder in Water-Mediated Dissociation of Pharmaceutical Cocrystal Systems.

Kaur N, Duggirala NK, Thakral S, Suryanarayanan R. Kaur N, et al. Mol Pharm. 2019 Jul 1;16(7):3167-3177. doi: 10.1021/acs.molpharmaceut.9b00386. Epub 2019 Jun 4. Mol Pharm. 2019. PMID: 31117742

6

Use of Atomic Force Microscopy (AFM) to monitor surface crystallization in caffeine-oxalic acid (CAFOXA) cocrystal compacts.

Kaur N, Haugstad G, Suryanarayanan R. Kaur N, et al. Int J Pharm. 2021 Nov 20;609:121196. doi: 10.1016/j.ijpharm.2021.121196. Epub 2021 Oct 16. Int J Pharm. 2021. PMID: 34662647

7

Physicochemical changes and chemical degradation of gliclazide during twin-screw melt granulation.

Liu T, Kaur N, Chen B, Phillips B, Chang SY, Yang F, Bi V, Durig T, Zhang F. Liu T, et al. Among authors: kaur n. Int J Pharm. 2022 May 10;619:121702. doi: 10.1016/j.ijpharm.2022.121702. Epub 2022 Mar 25. Int J Pharm. 2022. PMID: 35341908

8

Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption.

Kaur N, Narang A, Bansal AK. Kaur N, et al. Eur J Pharm Biopharm. 2018 Aug;129:222-246. doi: 10.1016/j.ejpb.2018.05.024. Epub 2018 Jun 4. Eur J Pharm Biopharm. 2018. PMID: 29879527 Review.

9

Understanding the Oral Absorption of Irbesartan Using Biorelevant Dissolution Testing and PBPK Modeling.

Kaur N, Thakur PS, Shete G, Gangwal R, Sangamwar AT, Bansal AK. Kaur N, et al. AAPS PharmSciTech. 2020 Mar 9;21(3):102. doi: 10.1208/s12249-020-01643-x. AAPS PharmSciTech. 2020. PMID: 32152915 Clinical Trial.

10

The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells.

Rosier M, Krstulović A, Kim HR, Kaur N, Enakireru EM, Symmes D, Dobra K, Chen R, Evans CA, Gad AKB. Rosier M, et al. Among authors: kaur n. Cancers (Basel). 2024 Dec 30;17(1):81. doi: 10.3390/cancers17010081. Cancers (Basel). 2024. PMID: 39796712 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,512 results

Search Page

Filters